20 CFR 30.200
§ 30.200 What is the scope of this subpart?
United States · 20 CFR — Employees' Benefits · Status: effective
Cite this
- Citation
- 20 CFR 30.200, § 30.200 What is the scope of this subpart?, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/76716
- Permanent ID
ys:prov:76716@1- SHA-256
6472a7cdf727ee5f45b68bfb654887f4d744e4ed7fb5c8df9b311e95d822f6fd
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
The regulations in this subpart describe the criteria for eligibility for benefits for claims under Part B of EEOICPA relating to covered beryllium illness under sections 7384l, 7384n, 7384s and 7384t of the Act; for cancer under sections 7384l, 7384n, 7384q and 7384t of the Act; for chronic silicosis under sections 7384l, 7384r, 7384s and 7384t of the Act; and for claims relating to covered uranium employees under sections 7384t and 7384u of the Act. These regulations also describe the criteria for eligibility for benefits for claims under Part E of EEOICPA relating to covered illnesses under sections 7385s-4 and 7385s-5 of the Act. This subpart describes the type and extent of evidence that will be necessary to establish the criteria for eligibility for compensation for these illnesses.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.